Pages that link to "Q50621222"
Jump to navigation
Jump to search
The following pages link to Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children (Q50621222):
Displaying 50 items.
- Injection allergen immunotherapy for asthma (Q24236566) (← links)
- Allergen immunotherapy for asthma (Q24247724) (← links)
- Allergen-specific immunotherapy in pediatric allergic asthma (Q26739254) (← links)
- United airway disease: current perspectives (Q26743436) (← links)
- Sublingual Immunotherapy: A Useful Tool for the Allergist in Private Practice (Q26747200) (← links)
- Role of immunotherapy in the treatment of allergic asthma (Q27021489) (← links)
- Allergen exposure and the development of asthma (Q30307760) (← links)
- Update on allergy immunotherapy (Q30436062) (← links)
- Sublingual immunotherapy: World Allergy Organization position paper 2013 update (Q30440195) (← links)
- Sublingual immunotherapy in children with allergic rhinitis: quality of systematic reviews (Q31030974) (← links)
- Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment (Q33378244) (← links)
- Immunotherapy in asthma: an updated systematic review (Q33760677) (← links)
- Preventive actions of allergen immunotherapy: the facts and the effects in search of evidence (Q33802263) (← links)
- Asthma: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases (Q33956813) (← links)
- Does allergen immunotherapy alter the natural course of allergic disorders? (Q34212909) (← links)
- Allergic rhinitis/asthma interrelationships (Q34318525) (← links)
- Specific immunotherapy in rhinitis and asthma. (Q34321324) (← links)
- Recombinant house dust mite allergens. (Q34361546) (← links)
- Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma (Q34375745) (← links)
- IL-4 attenuates pulmonary epithelial cell-mediated suppression of T cell priming (Q34430368) (← links)
- Immunotherapy for house dust mite sensitivity: where are the knowledge gaps? (Q34445398) (← links)
- Evidence-based treatment of allergic rhinitis (Q34561629) (← links)
- Allergic rhinitis in children (Q34561808) (← links)
- Can we apply clinical studies to real life? Evidence-based recommendations from studies on development of allergic diseases and allergy prevention (Q34612159) (← links)
- Differential regulation of IL-4Ralpha expression by antigen versus cytokine stimulation characterizes Th2 progression in vivo (Q34732223) (← links)
- Diseases of the nose and paranasal sinuses in child (Q34751071) (← links)
- Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7-10 December 1999, Geneva, Switzerland (Q34778060) (← links)
- Immunotherapy for allergic asthma (Q34997913) (← links)
- The need for patient-focused therapy for children and teenagers with allergic rhinitis: a case-based review of current European practice (Q35052674) (← links)
- Allergy testing in children: why, who, when and how? (Q35161090) (← links)
- Overview of allergic rhinitis (Q35168242) (← links)
- Primary and secondary prevention of allergic airway disease. (Q35184885) (← links)
- Immunotherapy in fungal allergy (Q35195256) (← links)
- Early detection of allergic diseases in otorhinolaryngology (Q35427549) (← links)
- Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol. (Q35540640) (← links)
- New therapies for asthma: Where next? (Q35547834) (← links)
- Recognizing And Treating Non‐Infectious Rhinitis (Q35560045) (← links)
- Allergic rhinitis in children : diagnosis and management strategies (Q35875669) (← links)
- Immunotherapy in the age of anti-IgE. (Q35970684) (← links)
- Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review (Q36215069) (← links)
- Food-specific sublingual immunotherapy is well tolerated and safe in healthy dogs: a blind, randomized, placebo-controlled study (Q36253230) (← links)
- Efficacy and safety of allergen immunotherapy in children (Q36404330) (← links)
- Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses (Q36411170) (← links)
- Pollen immunotherapy: selection,prevention, and future directions (Q36561253) (← links)
- The regulation of allergy and asthma (Q36563540) (← links)
- Accelerated immunotherapy schedules: review of efficacy and safety (Q36579814) (← links)
- Sublingual immunotherapy of allergic diseases (Q36583727) (← links)
- Oral mucosal immunotherapy for allergic rhinitis: A pilot study (Q36814140) (← links)
- Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction (Q36826600) (← links)
- Duration of allergen immunotherapy in respiratory allergy: when is enough, enough? (Q36829985) (← links)